Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24.
Amylyx Pharmaceuticals Inc. (AMLX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 2,471,455 | $7,018,932 | +9% | 0% |
| 2. | 1,679,125 | $4,768,715 | 0.08% | ||
| 3. | Citadel Investment Group Ken Griffin | 1,330,384 | $3,778,291 | -41% | 0% |
| 4. | Farallon Capital Thomas Steyer | 1,150,221 | $3,266,628 | 0.01% | |
| 5. | 1,060,100 | $3,010,684 | -19% | 0.33% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.89 | 2,250 | 5,000 | 2024-05-15 | Filing | ||
| $1.89 | 2,750 | 2,750 | 2024-05-14 | Filing | ||
| $14.97 | 4,000 | 5,000 | 2023-12-15 | Filing | ||
| $31.99 | 1,000 | Director | 1,000 | 2023-03-16 | Filing | |
| $19.00 | 263,158 | Large Shareholder | 10,678,808 | 2022-01-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.88 | 10,455 | 151,477 | 2024-05-15 | Filing | ||
| $18.73 | 4,135 | 3,023,002 | 2024-03-05 | Filing | ||
| $18.73 | 4,135 | 2,959,308 | 2024-03-05 | Filing | ||
| $18.73 | 1,792 | 134,784 | 2024-03-05 | Filing | ||
| $18.73 | 1,540 | 81,372 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,275,566 | $77,656,332 | 0% | |
| 2. | 4,002,334 | $58,914,357 | 0% | |
| 3. | 2,830,243 | $41,661,177 | 0% | |
| 4. | 1,441,402 | $21,217,437 | 0% | |
| 5. | 1,436,151 | $21,140,143 | 0% |
News See All
5 Best Value Penny Stocks To Invest In Now
“Furthermore, Five Point Holdings, LLC (NYSE:FPH) (a U.S.-based land development company) launched an exchange offer for its Senior Unsecured Notes, whereby it proposed to pay down $100 million of...
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.2. Amylyx Pharmaceuticals, Inc.
5 Small-Cap Stocks with High Potential
In this article, we will take a look at the 5 small-cap stocks with high potential.
5 Best IPO Stocks to Buy Heading into 2024
In this article, we will take a look at the 5 best IPO stocks to buy heading into 2024.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
Billionaire Hedge Funds
